We are live on ! Find out more
NVCR icon

NovoCure
NVCR

238 hedge funds and large institutions have $1.24B invested in NovoCure in 2025 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 100 increasing their positions, 61 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

191% more call options, than puts

Call options by funds: $16.7M | Put options by funds: $5.74M

64% more repeat investments, than reductions

Existing positions increased: 100 | Existing positions reduced: 61

10% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 40

3.34% more ownership

Funds ownership: 82.04% → 85.38% (+3.3%)

4% more capital invested

Capital invested by funds: $1.19B → $1.24B (+$50.9M)

2% less funds holding

Funds holding: 244 → 238 (-6)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
238
Holders Change
-6
Holders Change %
-2.46%
% of All Funds
2.89%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
44
Increased
100
Reduced
61
Closed
40
Calls
$16.7M
Puts
$5.74M
Net Calls
+$11M
Net Calls Change
-$5M

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$53.3M
2
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$14.4M
3
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
+$11.9M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$10.1M
5
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$7.38M

Top Sellers

1
Capital World Investors
Capital World Investors
California
-$25.8M
2
SCM
Soleus Capital Management
Connecticut
-$14.3M
3
Marshall Wace
Marshall Wace
United Kingdom
-$13.4M
4
UBS AM
UBS AM
Illinois
-$12.4M
5
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$12.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
FFP
251
FourThought Financial Partners
Florida
– -$267K -20,683 Closed
Kovitz Investment Group Partners
252
Kovitz Investment Group Partners
Illinois
– -$253K -19,574 Closed
EMFAT
253
Emerald Mutual Fund Advisers Trust
Pennsylvania
– -$248K -19,173 Closed
FMI
254
F/M Investments
District of Columbia
– -$248K -19,173 Closed
VF
255
Virtu Financial
New York
– -$222K -17,172 Closed
Capstone Investment Advisors
256
Capstone Investment Advisors
New York
– -$213K -16,464 Closed
BC
257
Bridgefront Capital
Texas
– -$202K -15,659 Closed
PWM
258
Prosperity Wealth Management
California
– -$190K -14,710 Closed
Teacher Retirement System of Texas
259
Teacher Retirement System of Texas
Texas
– -$179K -13,853 Closed
AI
260
Atom Investors
Texas
– -$178K -13,740 Closed
Prudential Financial
261
Prudential Financial
New Jersey
– -$157K -12,155 Closed
CL
262
Choreo LLC
Illinois
– -$136K -10,545 Closed
RS
263
R Squared
Hong Kong
– -$134K -10,374 Closed
Lazard Asset Management
264
Lazard Asset Management
New York
– -$131K -10,115 Closed
EA
265
Emerald Advisers
Pennsylvania
– -$16.9K -1,311 Closed
Optiver Holding
266
Optiver Holding
Netherlands
– -$8.09K -626 Closed
GLF
267
Groupe la Francaise
France
– -$4.62K -420 Closed
ASN
268
Advisory Services Network
Georgia
– -$5.22K -404 Closed
TSMHT
269
Thurston Springer Miller Herd & Titak
Indiana
– -$4.43K -343 Closed
SHIM
270
Stone House Investment Management
Pennsylvania
– -$2.49K -193 Closed
ACM
271
Aster Capital Management
United Arab Emirates
– -$2.36K -183 Closed
PFA
272
Pillar Financial Advisors
Kentucky
– -$1.78K -138 Closed
WAM
273
Wolverine Asset Management
Illinois
– -$1.32K -102 Closed
Bessemer Group
274
Bessemer Group
New Jersey
– -$1K -81 Closed
QC
275
Quent Capital
New York
– -$711 -55 Closed
8 9 10
11
12

NVCR Hedge Fund Activity: Q4 2025 in Review

238 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in NovoCure (NVCR) for Q4 2025, worth a combined $1.24B — up 4.3% from $1.19B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new NVCR positions and 40 closed out — a net gain of 4 holders — while 100 added to existing stakes and 61 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $53.3M. The largest seller was Capital World Investors, exiting entirely with an estimated $25.8M sold.

  • 238 institutional investors held NovoCure (NVCR) as of Q4 2025, down from 244 in Q3 2025.
  • Funds reported $1.24B of NovoCure stock for Q4 2025, up 4.3% quarter-over-quarter.
  • 44 funds opened new NovoCure positions in Q4 2025 and 40 closed out, a net change of +4 holders.
  • The largest NovoCure buyer in Q4 2025 was Morgan Stanley, an estimated $53.3M added.
  • The largest NovoCure seller in Q4 2025 was Capital World Investors, an estimated $25.8M sold.

Based on aggregated 13F filings for Q4 2025.